Zelenectide pevedotin
Highest phase reached
Phase 2
Drug type
Protein
- Listing at source
- Listed
- Highest phase reached
- Phase 2
- Drug type
- Protein
- Drug name
- Zelenectide pevedotin
- bt 8009
- BT-8009
- bt8009
- Bt8009
- BT8009
- zelenectida pevedotina
- Zelenectida pevedotina
- zelenectide pavedotin
- Zelenectide pavedotin
- ZELENECTIDE PAVEDOTIN [USAN]
- zelenectide pavedotin usan
- zelenectide pevedotin
- Zelenectide pevedotin
- Zelenectide pevedotin (BT8009)
- zelenectide pevedotin [INN]
- Zelenectide pevedotin [WHO-DD]
- zelenectide pevedotin inn
- zelenectide pevedotin who dd
- zelenectide pevedotine
- Zelenectide pevedotine
- CAS registry numbers
- 2407446-48-2
- ChEMBL ID
- CHEMBL5314903
- FDA ingredient codes (UNII)
- 0IN1TZ844E
- First in class
- No
- Orphan designation
- No
- Drug name stem
- -dotin; -tide
- Condition
- Neoplasms
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000616
- Subject identifier
- D009369
- Condition
- Neoplasms
- Highest recorded phase
- 2
- Condition identifier
- MONDO:0004992
- Subject identifier
- D009369
- Condition identifier
- EFO_0000616
- Condition identifier
- EFO_0003060
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0004992
- Condition identifier
- MONDO_0005070
- Condition identifier
- MONDO_0005233
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0007254
- Highest recorded phase
- 2
Trial references
- NCT06225596
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (5)
- Bicycle Continued Access Protocol (BiCAP) for Participants Receiving a Bicycle Investigational Product
- Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
- Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
- Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
- Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
In development for (4)
- Breast cancer Phase 2
- Cancer Phase 2
- Neoplasm Phase 2
- Non-small cell lung carcinoma Phase 2